Evaluation of the Accelerated Traction of Impacted Canines in Terms of Speed and Changes in the Dental Arches

NCT05891665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-06-07

No results posted yet for this study

Summary

The time required for orthodontic traction of impacted canines after surgical exposure is a particularly troubling clinical problem because it prolongs the orthodontic treatment duration. During traction process, several complications could result in alveolar bone loss, root resorption of the adjacent teeth, ankylosis, discoloration, loss or vitality and gingival recession. Accordingly, and due to the lack of studies concerned with accelerating the traction movement of the impacted canines, we conducted this study to evaluate the effectiveness of some surgical interventions (corticotomy and Piezocision) in increasing the rate of orthodontic traction movement. We also aimed to evaluate dentoalveolar changes associated with the use of such accelerating procedures compared with the conventional traction method.

Conditions

  • Impacted Tooth With Abnormal Positioning

Interventions

PROCEDURE

Corticotomy

A corticotomy procedure will be applied with some osteoperforations during the surgical exposure of the impacted canine. Then this will be followed after 8 weeks with another surgical stimulation using piezosurgery.

PROCEDURE

Traditional traction of the impacted canine without corticotomy

In this group of patients, the traction of the impacted canine will be performed traditionally without the involvement of additional surgical intervention.

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Mahran R. Mousa, DDS MSc · PhD student at the Department of Orthodontics

  • Mohammad Y Hajeer, DDS MSc PhD · Professor of Orthodontics, Faculty of Dentistry, University of Damascus

  • Omar Heshmeh, DDS MSc PhD · Professor of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Damascus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2022-12-01
Completion
2023-03-12

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05891665 on ClinicalTrials.gov